Human Psychopharmacology

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Aim and Scope

Human Psychopharmacology: Clinical and Experimental provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines. Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered. While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome.

About Human Psychopharmacology

Human Psychopharmacology is a journal covering the technologies/fields/categories related to Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3). It is published by John Wiley and Sons Ltd. The overall rank of Human Psychopharmacology is 11356. According to SCImago Journal Rank (SJR), this journal is ranked 0.449. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 84. The best quartile for this journal is Q3.

The ISSN of Human Psychopharmacology journal is 10991077, 08856222. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Human Psychopharmacology is cited by a total of 200 articles during the last 3 years (Preceding 2022).

Human Psychopharmacology Impact IF 2022-2023

The Impact IF 2022 of Human Psychopharmacology is 1.70, which is computed in 2023 as per its definition. Human Psychopharmacology IF is decreased by a factor of 0.7 and approximate percentage change is -29.17% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Human Psychopharmacology Impact IF 2023 Prediction

Impact IF 2022 of Human Psychopharmacology is 1.70. If the same downward trend persists, Impact IF may fall in 2023 as well.

Human Psychopharmacology h-index

 

Human Psychopharmacology has an h-index of 84. It means 84 articles of this journal have more than 84 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Human Psychopharmacology ISSN

The ISSN of Human Psychopharmacology is 10991077, 08856222. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Human Psychopharmacology Rank and SCImago Journal Rank (SJR)

The overall rank of Human Psychopharmacology is 11356. According to SCImago Journal Rank (SJR), this journal is ranked 0.449. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Human Psychopharmacology by Year

Ranking of Human Psychopharmacology by Year

Human Psychopharmacology Publisher

Human Psychopharmacology is published by John Wiley and Sons Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1986-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

Call For Papers

Visit the official website of the journal/conference to check the further details about the call for papers.

Abbreviation

The IS0 4 standard abbreviation of Human Psychopharmacology is Hum. Psychopharmacol.. This abbreviation ('Hum. Psychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.

How to publish in Human Psychopharmacology

If your research field is/are related to Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3), then please visit the official website of this journal.

Acceptance Rate

The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

• The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
• Peer review complexity and timeline.
• The mix of unsolicited and invited submissions.
• The time it takes from manuscript submission to final publication.
• And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/